Table 4 Logistic regression analysis for BALF recovery failure in the RM/LL group.
From: Predictors for bronchoalveolar lavage recovery failure in diffuse parenchymal lung disease
| Â | OR | 95% CI | P-value |
|---|---|---|---|
Univariate | |||
Age, per year | 1.03 | 0.99–1.05 | 0.09 |
Men (vs. women) | 5.64 | 2.34–13.6 |  < 0.01* |
Smoking, current/ex (vs. never) | 3.95 | 1.80–8.65 |  < 0.01* |
Smoking, per 1 pack-years increase | 1.02 | 1.01–1.03 |  < 0.01* |
Pulmonary function | |||
FVC, per 100 mL increase | 1.03 | 0.99–1.07 | 0.08 |
%FVC, per 1% increase | 1.00 | 0.98–1.02 | 0.99 |
FEV1.0, per 100 mL increase | 1.02 | 0.97–1.06 | 0.50 |
%FEV1.0, per 1% increase | 0.99 | 0.97–1.01 | 0.19 |
FEV1.0/FVC, per 1% increase | 0.96 | 0.93–0.99 |  < 0.01* |
BAL target site, ML (vs. LL) | 0.91 | 0.40–2.06 | 0.82 |
HRCT analysis | |||
Lung volume of BAL side, 100 mL increase | 1.08 | 1.03–1.13 |  < 0.01* |
%LAA in BAL side, per 1% increase | 0.99 | 0.96–1.02 | 0.70 |
Multivariate | |||
Men (vs. women) | 3.87 | 1.44–10.4 |  < 0.01* |
Smoking, per 1 pack-years increase | 1.01 | 0.99–1.02 | 0.27 |
FEV1.0/FVC, per 1% increase | 0.97 | 0.94–0.99 | 0.04* |
Lung volume of BAL side, 100 mL increase | 1.00 | 0.99–1.01 | 0.42 |
